Clinical Trials Directory

Trials / Completed

CompletedNCT00984308

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
225 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.

Detailed description

The project sought to evaluate whether a diagnostic and therapeutic intervention strategy among Veterans with cerebrovascular disease and hypertension using unattended polysomnography and auto-titrating CPAP with a targeted adherence evaluation and educational protocol resulted in: an improved rate of diagnosed sleep apnea, an improved rate of treated sleep apnea, and improved blood pressure control.

Conditions

Interventions

TypeNameDescription
PROCEDURECPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)Continuous Positive Airway Pressure (CPAP) is provided for those patients who are diagnosed with OSA.

Timeline

Start date
2008-12-23
Primary completion
2011-09-30
Completion
2011-09-30
First posted
2009-09-25
Last updated
2017-06-14
Results posted
2015-09-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00984308. Inclusion in this directory is not an endorsement.